Risk factors for drug-resistant pathogens in community-acquired and healthcare-associated pneumonia. - Wikidata - wikimedia - TriplyDB

Risk factors for drug-resistant pathogens in community-acquired and healthcare-associated pneumonia.

Risk factors for drug-resistant pathogens in community-acquired and healthcare-associated pneumonia.

http://www.wikidata.org/entity/Q42608997

about

Year in review 2013: Critical Care--respiratory infections Treatment of Gram-positive infections in critically ill patients Current and Future Considerations for the Treatment of Hospital-Acquired Pneumonia Antibiotic stewardship in the intensive care unit.Predictive Factors of Methicillin-Resistant Staphylococcus aureus Infection in Elderly Patients with Community-Onset Pneumonia.Epidemiology and predictors of multidrug-resistant community-acquired and health care-associated pneumonia.A comparison of microbiology and demographics among patients with healthcare-associated, hospital-acquired, and ventilator-associated pneumonia: a retrospective analysis of 1184 patients from a large, international study Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management.Clinical implications for patients treated inappropriately for community-acquired pneumonia in the emergency department.Update in sepsis and pulmonary infections 2013.The burden and etiology of community-onset pneumonia in the aging Japanese population: a multicenter prospective study.Molecular epidemiological characteristics of Klebsiella pneumoniae associated with bacteremia among patients with pneumonia.Individualizing risk of multidrug-resistant pathogens in community-onset pneumonia.Bacteriological assessment of healthcare-associated pneumonia using a clone library analysis An international multicenter retrospective study of Pseudomonas aeruginosa nosocomial pneumonia: impact of multidrug resistance.Comparison of clinical prediction models for resistant bacteria in community-onset pneumonia.Mechanisms of antimicrobial resistance in Gram-negative bacilli.A mortality prediction rule for non-elderly patients with community-acquired pneumonia The significance of oral streptococci in patients with pneumonia with risk factors for aspiration: the bacterial floral analysis of 16S ribosomal RNA gene using bronchoalveolar lavage fluid Trends in Antibiotic Use and Nosocomial Pathogens in Hospitalized Veterans With Pneumonia at 128 Medical Centers, 2006-2010.Derivation and Multicenter Validation of the Drug Resistance in Pneumonia Clinical Prediction Score.A cohort study of bacteremic pneumonia: The importance of antibiotic resistance and appropriate initial therapy?Relation between presence of extended-spectrum β-lactamase-producing Enterobacteriaceae in systematic rectal swabs and respiratory tract specimens in ICU patients.Are third-generation cephalosporins unavoidable for empirical therapy of community-acquired pneumonia in adult patients who require ICU admission? A retrospective study The bacterial pneumonias: a new treatment paradigm.Regional differences in antibiotic-resistant pathogens in patients with pneumonia: Implications for clinicians.The respiratory threat posed by multidrug resistant Gram-negative bacteria.Variation in Empiric Coverage Versus Detection of Methicillin-Resistant Staphylococcus aureus and Pseudomonas aeruginosa in Hospitalizations for Community-Onset Pneumonia Across 128 US Veterans Affairs Medical Centers.Sepsis: Current Definition, Pathophysiology, Diagnosis, and Management.Health care-associated pneumonia in the intensive care unit: Guideline-concordant antibiotics and outcomes.Clinical predictors of methicillin-resistant Staphylococcus aureus in nosocomial and healthcare-associated pneumonia: a multicenter, matched case-control study.Impact of Combination Antibiogram and Related Education on Inpatient Fluoroquinolone Prescribing Patterns for Patients With Health Care-Associated Pneumonia.The First Case of Pseudomonas aeruginosa Bacteremic Pneumonia in a Cancer Patient Receiving Pegfilgrastim.Risk factors associated with potentially antibiotic-resistant pathogens in community-acquired pneumonia.Predictors of Pseudomonas and methicillin-resistant Staphylococcus aureus in hospitalized patients with healthcare-associated pneumonia.Interleukin 7 immunotherapy improves host immunity and survival in a two-hit model of Pseudomonas aeruginosa pneumonia.Staphylococcus aureus Community-acquired Pneumonia: Prevalence, Clinical Characteristics, and Outcomes.Pseudomonas aeruginosa nosocomial pneumonia: impact of pneumonia classification.Risk factors for multidrug-resistant pathogens in bronchiectasis exacerbations.Healthcare-associated pneumonia: a never-ending story.

P2860

Q27003346-9C4AD3E4-B720-4B6C-B0ED-C9F8C068206E Q27015976-84B720B8-2EF7-415D-AE5B-343E3FF0F120 Q28071882-BADB7F46-CEA3-4CE5-9C4C-91423CBDAF05 Q30408712-CB60695D-ACE1-4937-AE08-6A99EE16ADEF Q33567395-90AAD8E3-8B04-452D-AE64-BF7F85F54605 Q34057602-FD92C61E-7262-4052-9C0E-1C1BFA32A365 Q34464399-2F9E2A8A-3DAF-4336-A2BD-CDACB48785C2 Q34478074-92372E8E-F012-4E29-913A-9C6A00F3D9FA Q35086947-0826A0A2-A050-45C3-A500-97B5B6FF6967 Q35199001-C8E5E221-996D-4746-BC9D-ABBB1E8595F1 Q35231034-D0446B4E-3F34-4C8F-BFC4-AE6E859F27A8 Q35331017-BEB9770E-8351-472F-99FC-2DCF6A162C2E Q35362847-A2E614A2-0E9E-464D-B636-ABA1AD6FE566 Q35432136-455CB357-2C41-471A-AB3E-4AB2FA2008AA Q35658881-D1E1A69C-F3C0-40B3-834A-97E26582CAF4 Q35732814-89BDD752-426F-4C02-B752-6EC7FE13009D Q35935319-B2BF9F22-4BFD-4A60-BAEE-302AB1C04653 Q35949943-721FD248-E735-41E6-B755-6C7AC12473E2 Q36015030-CD6AE68A-5C5C-4F49-BF24-89256567578C Q36141276-A1C5849E-8879-4AEB-8D5D-EC62401C694C Q36888089-EB08B8F9-41C6-421E-A68B-AFD9C64426F2 Q37226357-56180C77-859A-4BC2-8CCE-029EC29D9019 Q37622014-3409C5E2-486C-41F3-9D1C-7C9F9E84DF78 Q37721755-C2D5709F-61AE-49BD-86DD-D4EC783902BD Q38307688-CA9003D6-289C-449E-B60A-A3577201C2B7 Q38646554-F2E45BC3-AFE9-4571-8EB9-199EEC0BC49E Q38662137-04C4A806-650D-451E-A31C-2033A13D29E7 Q38716765-8265CAB8-7E06-4C95-85B8-E2F078BBD85A Q39326078-BE5BCFEB-B3D3-4B7C-B509-B249A73A69FE Q39422204-DD14E00D-6A64-4DF3-BBAF-5718A4635F95 Q40059530-B011F35C-9834-4208-BFF5-2614DC4899C3 Q40090523-C6EC9206-BD19-436F-93A7-DB2421F36176 Q40109292-E269F82C-3586-4D53-893D-072318AC6FAE Q40177316-27565D46-F8DC-40FF-BD83-29A24569348E Q40196287-C8EE8AA4-E719-45EC-B628-E3E7DFBE9BF4 Q40539825-AF13EB28-62E2-4BE4-867F-6CF9B0908B23 Q40681222-E7BDB3F8-B4F1-4CDD-A940-2563591CB250 Q41100567-3B783809-AC72-4E8B-B76C-08CCEE4190F3 Q41992671-689045EF-F29F-4738-A0C0-7975CE050254 Q42060365-3C9A1BCB-4392-409B-8F58-418A91C63A1F

P2860

Risk factors for drug-resistant pathogens in community-acquired and healthcare-associated pneumonia.

http://www.wikidata.org/entity/Q42608997

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Risk factors for drug-resistan ...... althcare-associated pneumonia.

@en

Risk factors for drug-resistan ...... althcare-associated pneumonia.

@nl

type

label

Risk factors for drug-resistan ...... althcare-associated pneumonia.

@en

Risk factors for drug-resistan ...... althcare-associated pneumonia.

@nl

prefLabel

Risk factors for drug-resistan ...... althcare-associated pneumonia.

@en

Risk factors for drug-resistan ...... althcare-associated pneumonia.

@nl

P1433

Q42608997-400EEF7D-C2E6-4F9A-9E78-646A426602B4

P1476

Q42608997-CF4FE53F-7A5A-4493-84EE-EB73D45DF0C0

P2093

Q42608997-0234E0E5-5FF9-4B15-AE16-494AFCAF62E3

Q42608997-02E7160E-D2BE-4D12-A949-FECA726DA031

Q42608997-0318209A-9CEA-4381-B778-3E19F8B6AE4A

Q42608997-04F3CC4A-EDDF-4C07-A44E-CD8DE615C532

Q42608997-0595C693-5811-4AFE-AF7A-2166D23464F5

Q42608997-066226FE-ECB5-467C-A3BA-F6924AB818D5

Q42608997-095475AF-F4E9-4B59-921D-8062ED79D023

Q42608997-23EE91F4-76CF-4598-B001-1DE67D3D032A

Q42608997-312A0AFE-F645-4EB7-9B47-D29C22E9AB8A

Q42608997-573EFFF7-5E9E-49E2-BB04-1F7F29DDBCEF

P2860

Q42608997-01010480-D733-427A-AAA9-D1C09E0E3B52

Q42608997-1791960F-529A-432C-9080-00D76591BA9D

Q42608997-2D5DFE78-3DBA-4931-8682-DB6E8B76927E

Q42608997-2F537C8B-AABA-499D-BB22-D82136BB9E56

Q42608997-33B4B9A8-E011-475A-8410-3BBB096E752B

Q42608997-47AECAE1-DAE8-4679-9673-3DF96579468D

Q42608997-5161A592-2BAE-4B1B-AB76-DB0E80BB9EC7

Q42608997-58BA828B-1A1C-4E3A-B4F9-29463B25CE35

Q42608997-59DB4E26-29F2-4A7B-8A4D-BD9B1E51109F

Q42608997-5E416F7B-91A1-46BC-BBD6-186228213819

P304

Q42608997-BC3F52CF-EBE5-4B47-B4C0-3176C5B7C7AD

P31

Q42608997-AF2189F8-76E0-4FDC-8D8B-398DB07F06B1

P356

Q42608997-86DBA453-D3FC-4462-8F6F-30D3732E6B99

P407

Q42608997-81C4E832-1205-4AC8-AEF3-102EB4B67859

P433

Q42608997-CAF9548E-F3BB-4B59-A288-6FA84091499D

P478

Q42608997-0ACEE980-591E-4DB8-AEC4-CFD149122914

P577

Q42608997-D28031A2-F295-47ED-8D6E-7BDF9DA24180

P698

Q42608997-186CD446-E318-48C7-8A22-0550A291BB3B

P356

RCCM.201301-0079OC

P1433

American Journal of Respiratory and Critical Care Medicine

P1476

Risk factors for drug-resistan ...... althcare-associated pneumonia.

@en

P2093

Akira Shiraki

http://www.w3.org/2001/XMLSchema#string

Daisuke Kobayashi

http://www.w3.org/2001/XMLSchema#string

Fumio Nomura

http://www.w3.org/2001/XMLSchema#string

Hideo Saka

http://www.w3.org/2001/XMLSchema#string

Hiroshi Saito

http://www.w3.org/2001/XMLSchema#string

Hiroyuki Taniguchi

http://www.w3.org/2001/XMLSchema#string

Ikuo Yamaguchi

http://www.w3.org/2001/XMLSchema#string

Joe Shindoh

http://www.w3.org/2001/XMLSchema#string

Junya Okumura

http://www.w3.org/2001/XMLSchema#string

Mai Iwaki

http://www.w3.org/2001/XMLSchema#string

P2860

Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia

Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults

Predicting antibiotic resistance to community-acquired pneumonia antibiotics in culture-positive patients with healthcare-associated pneumonia

Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention

Epidemiology and outcomes of health-care-associated pneumonia: results from a large US database of culture-positive pneumonia

A prediction rule to identify low-risk patients with community-acquired pneumonia

Outcomes of patients hospitalized with community-acquired, health care-associated, and hospital-acquired pneumonia

Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance

Healthcare-associated pneumonia among hospitalized patients in a Korean tertiary hospital.

Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs.

P304

985-995

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1164/RCCM.201301-0079OC

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

188

http://www.w3.org/2001/XMLSchema#string

P577

2013-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23855620

http://www.w3.org/2001/XMLSchema#string